3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Vitamin D Deficiency
17
Prostatic Neoplasms
14
Neoplasms
9
Polycystic Ovary Syndrome
8
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Myelodysplastic Syndromes
5
Osteoporosis
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
Etanercept
12
Adalimumab
12
Infliximab
7
golimumab
4
Tumor Necrosis Factor Inhibitors
4
Certolizumab Pegol
4
Abatacept
4
tofacitinib
2
tocilizumab
2
Rituximab
2
Antirheumatic Agents
2
Vitamin D
1
Vaccines
1
Syringes
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Radioimmunodetection
1
Prednisone
1
Practice Guidelines as Topic
1
Phlebotomy
1
Observation
1
Nivolumab
1
Methotrexate
1
Methods
1
Lysine Acetyltransferase 5
1
Licensure
1
Leflunomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis, Rheumatoid
×
Cholecalciferol
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts